Suppr超能文献

仅在 TATA 结合蛋白基因的 TATA 盒中具有轻微扩展的 CAG/CAA 重复的 SCA17 家族中严重且快速进展的认知表型:病例报告。

Severe and rapidly progressing cognitive phenotype in a SCA17-family with only marginally expanded CAG/CAA repeats in the TATA-box binding protein gene: a case report.

机构信息

Memory Disorders Research Group, Neurogenetics Clinic, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

出版信息

BMC Neurol. 2012 Aug 13;12:73. doi: 10.1186/1471-2377-12-73.

Abstract

BACKGROUND

The autosomal dominant spinocerebellar ataxias (SCAs) confine a group of rare and heterogeneous disorders, which present with progressive ataxia and numerous other features e.g. peripheral neuropathy, macular degeneration and cognitive impairment, and a subset of these disorders is caused by CAG-repeat expansions in their respective genes. The diagnosing of the SCAs is often difficult due to the phenotypic overlap among several of the subtypes and with other neurodegenerative disorders e.g. Huntington's disease.

CASE PRESENTATION

We report a family in which the proband had rapidly progressing cognitive decline and only subtle cerebellar symptoms from age 42. Sequencing of the TATA-box binding protein gene revealed a modest elongation of the CAG/CAA-repeat of only two repeats above the non-pathogenic threshold of 41, confirming a diagnosis of SCA17. Normally, repeats within this range show reduced penetrance and result in a milder disease course with slower progression and later age of onset. Thus, this case presented with an unusual phenotype.

CONCLUSIONS

The current case highlights the diagnostic challenge of neurodegenerative disorders and the need for a thorough clinical and paraclinical examination of patients presenting with rapid cognitive decline to make a precise diagnosis on which further genetic counseling and initiation of treatment modalities can be based.

摘要

背景

常染色体显性遗传性小脑共济失调(SCA)是一组罕见且具有异质性的疾病,其特征为进行性共济失调和许多其他特征,如周围神经病、黄斑变性和认知障碍,其中一些疾病是由其各自基因中的 CAG 重复扩展引起的。由于几种亚型之间存在表型重叠,并且与其他神经退行性疾病(如亨廷顿病)存在重叠,因此 SCA 的诊断通常较为困难。

病例介绍

我们报告了一个家族,该家族中的先证者在 42 岁时出现了快速进展的认知能力下降,仅有轻微的小脑症状。TATA 框结合蛋白基因的测序显示,CAG/CAA 重复仅延长了两个重复,超过了非致病性阈值 41,证实了 SCA17 的诊断。通常,在此范围内的重复具有较低的外显率,导致疾病进程更温和,进展更慢,发病年龄更大。因此,该病例表现出一种不寻常的表型。

结论

目前的病例突出了神经退行性疾病的诊断挑战,需要对表现为快速认知能力下降的患者进行全面的临床和辅助检查,以便做出准确的诊断,从而为进一步的遗传咨询和治疗方案的启动提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/478f/3475097/d51fda61f852/1471-2377-12-73-1.jpg

相似文献

4
Small-expanded allele spinocerebellar ataxia 17: imaging and phenotypic variability.
Neurol Sci. 2021 Oct;42(10):4309-4315. doi: 10.1007/s10072-021-05313-z. Epub 2021 May 24.
5
Huntington's disease-like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation.
Parkinsonism Relat Disord. 2010 Jan;16(1):12-5. doi: 10.1016/j.parkreldis.2009.06.006.
6
Spinocerebellar Ataxia Type 17 (SCA17).
Adv Exp Med Biol. 2018;1049:219-231. doi: 10.1007/978-3-319-71779-1_10.
7
Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients.
J Neurol. 2007 Nov;254(11):1538-46. doi: 10.1007/s00415-007-0579-7. Epub 2007 Oct 15.
8
Spinocerebellar ataxia type 17 associated with an expansion of 42 glutamine residues in TATA-box binding protein gene.
J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1396-9. doi: 10.1136/jnnp.2009.180711. Epub 2010 Jun 28.
9
Spinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4).
Cerebellum. 2008;7(2):170-8. doi: 10.1007/s12311-008-0016-1.
10
Spinocerebellar ataxia type 17 is caused by mutations in the TATA-box binding protein.
Cerebellum. 2007;6(4):300-7. doi: 10.1080/14734220601136177. Epub 2007 Jan 19.

引用本文的文献

1
Molecular Mechanisms of Spinocerebellar Ataxia Type 17.
Mol Neurobiol. 2025 May;62(5):5720-5729. doi: 10.1007/s12035-024-04645-z. Epub 2024 Nov 30.
2
Tremor in Spinocerebellar Ataxia: A Scoping Review.
Tremor Other Hyperkinet Mov (N Y). 2024 Jun 20;14:31. doi: 10.5334/tohm.911. eCollection 2024.
4
Visual oculomotor abnormalities and vestibulo‑ocular reflex dynamics in polyglutamine spinocerebellar ataxias (Review).
Exp Ther Med. 2023 Jun 6;26(1):358. doi: 10.3892/etm.2023.12057. eCollection 2023 Jul.
5
Cognitive Dysfunction in Repeat Expansion Diseases: A Review.
Front Aging Neurosci. 2022 Apr 11;14:841711. doi: 10.3389/fnagi.2022.841711. eCollection 2022.
6
What is the Pathogenic CAG Expansion Length in Huntington's Disease?
J Huntingtons Dis. 2021;10(1):175-202. doi: 10.3233/JHD-200445.
7
Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.
Mol Neurobiol. 2020 Jan;57(1):566-584. doi: 10.1007/s12035-019-01724-4. Epub 2019 Aug 9.
9
The Pathogenic Role of Low Range Repeats in SCA17.
PLoS One. 2015 Aug 12;10(8):e0135275. doi: 10.1371/journal.pone.0135275. eCollection 2015.
10
Parkinsonism in spinocerebellar ataxia.
Biomed Res Int. 2015;2015:125273. doi: 10.1155/2015/125273. Epub 2015 Mar 19.

本文引用的文献

2
Spinocerebellar ataxia type 17 associated with an expansion of 42 glutamine residues in TATA-box binding protein gene.
J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1396-9. doi: 10.1136/jnnp.2009.180711. Epub 2010 Jun 28.
3
Structural changes associated with progression of motor deficits in spinocerebellar ataxia 17.
Cerebellum. 2010 Jun;9(2):210-7. doi: 10.1007/s12311-009-0150-4.
4
SCA17 repeat expansion: mildly expanded CAG/CAA repeat alleles in neurological disorders and the functional implications.
Clin Chim Acta. 2010 Mar;411(5-6):375-80. doi: 10.1016/j.cca.2009.12.002. Epub 2009 Dec 11.
5
Huntington's disease-like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation.
Parkinsonism Relat Disord. 2010 Jan;16(1):12-5. doi: 10.1016/j.parkreldis.2009.06.006.
6
A small trinucleotide expansion in the TBP gene gives rise to a sporadic case of SCA17 with abnormal putaminal findings on MRI.
Intern Med. 2008;47(24):2179-82. doi: 10.2169/internalmedicine.47.1499. Epub 2008 Dec 15.
8
The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment.
Parkinsonism Relat Disord. 2007 May;13(4):246-9. doi: 10.1016/j.parkreldis.2006.04.009. Epub 2006 Jun 21.
9
Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17.
Mov Disord. 2006 Jun;21(6):872-5. doi: 10.1002/mds.20827.
10
Putamen dopamine transporter and glucose metabolism are reduced in SCA17.
Ann Neurol. 2005 Sep;58(3):490-1. doi: 10.1002/ana.20609.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验